Taiwan FDA registration 9037e922e39cf7e31210efbc5ff11fa4

Resyno-One Injection

TW: 銳膝能關節內注射劑

Taiwan·Risk Class 3·MD·YooYoung Pharmaceutical Co., Ltd.·Registered Aug 14, 2023 – Aug 14, 2028Active

Registration details

Analysis ID: 9037e922e39cf7e31210efbc5ff11fa4
License Form: Ministry of Health Medical Device Import No. 036501
Customs Code: DHA05603650100

Company information

Manufacturer: YooYoung Pharmaceutical Co., Ltd.
Manufacturer Country: Korea, Republic of
Authorized Representative: UNIMED PHARMACEUTICAL ENTERPRISE CO., LTD.

Product details

Intended Use: This product is suitable for the treatment of pain with degenerative arthritis of the knee. And patients who are ineffective in non-drug treatment, non-steroidal anti-inflammatory drugs or general analgesics such as acetamide phenol.
Product Type (Level 1): N Orthopedics
Product Type (Level 2): N0003 Hyaluronic acid implants for the joint cavity
Import Information: Imported from abroad

Dates and status

Registration Date: Aug 14, 2023
Expiry Date: Aug 14, 2028

About this record

Access comprehensive regulatory information for Resyno-One Injection in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 9037e922e39cf7e31210efbc5ff11fa4 and manufactured by YooYoung Pharmaceutical Co., Ltd.. The authorized representative in Taiwan is UNIMED PHARMACEUTICAL ENTERPRISE CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.